Hikma advances its epinephrine nasal spray with multi-market regulatory filings

  • Post author:
  • Post category:Sales & Growth

LONDON, Sept. 10, 2026 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma, Group) announces that regulatory submissions for its epinephrine nasal spray, being developed for the emergency treatment of allergic reactions (anaphylaxis), have been accepted for review by regulators in…

Continue ReadingHikma advances its epinephrine nasal spray with multi-market regulatory filings

WellCare of Kentucky recognizes 2026 Community Health Champions

  • Post author:
  • Post category:Sales & Growth

12 winners receive awards, grants for their organizationsLOUISVILLE, Ky., Sept. 10, 2026 /PRNewswire/ -- WellCare of Kentucky honored 12 individuals and organizations at its seventh annual Community Health Champions Awards at Churchill Downs. The awards recognize people and organizations…

Continue ReadingWellCare of Kentucky recognizes 2026 Community Health Champions

Houston Couple Brings a Personal Approach to Recovery and Wellness to the Energy Corridor with New beem® Studio

  • Post author:
  • Post category:Sales & Growth

Locally owned wellness destination will offer private infrared sauna and red light therapy, with Founding Member rates available ahead of its mid-September opening.HOUSTON, Sept. 9, 2026 /PRNewswire/ -- For Clyde and Denia Smith, wellness is more than a…

Continue ReadingHouston Couple Brings a Personal Approach to Recovery and Wellness to the Energy Corridor with New beem® Studio

Cell Stem Cell: tBE-mediated Base Editing Therapy Achieves Durable Clinical Remission in Sickle Cell Disease and β-Thalassemia Across Different Genetic Backgrounds

  • Post author:
  • Post category:Sales & Growth

Following 100% transfusion independence in Chinese TDT patients, new study confirms tBE is equally safe and effective for African SCD patients and TDT patients from South/Southeast Asia.SHANGHAI, Sept. 7, 2026 /PRNewswire/ -- On September 7, 2026, Shanghai, Cell…

Continue ReadingCell Stem Cell: tBE-mediated Base Editing Therapy Achieves Durable Clinical Remission in Sickle Cell Disease and β-Thalassemia Across Different Genetic Backgrounds

In HelloNation, Eye Care Experts, Dr. Singh, and Dr. Sanka of Eye Centers of Racine and Kenosha, explain how interventional ophthalmology is changing treatment

  • Post author:
  • Post category:Sales & Growth

The article examines how earlier diagnosis and proactive eye care may help reduce long-term vision loss.RACINE, Wis., Sept. 7, 2026 /PRNewswire/ -- What is interventional eye care, and how is it changing treatment in Racine? HelloNation has published an…

Continue ReadingIn HelloNation, Eye Care Experts, Dr. Singh, and Dr. Sanka of Eye Centers of Racine and Kenosha, explain how interventional ophthalmology is changing treatment

Community-Acquired Bacterial Pneumonia Market Poised for Expansion During the Forecast Period (2026-2036) Amid Rising Antimicrobial Resistance and Therapeutic Advances | DelveInsight

  • Post author:
  • Post category:Sales & Growth

The community-acquired bacterial pneumonia market is poised for continued growth, driven by the substantial global disease burden, increasing hospitalization rates, an aging population, rising prevalence of comorbidities, and the growing challenge of antimicrobial resistance. Additionally, the launch of…

Continue ReadingCommunity-Acquired Bacterial Pneumonia Market Poised for Expansion During the Forecast Period (2026-2036) Amid Rising Antimicrobial Resistance and Therapeutic Advances | DelveInsight

Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults

  • Post author:
  • Post category:Sales & Growth

-- Positive Phase 2 (Australia) results strengthen potential best-in-class profile of RSV+hMPV±PIV3 combination vaccines, with the potential differentiated ability to re-vaccinate individuals previously receiving approved RSV vaccines to restore and broaden protection ---- Robust neutralizing antibody responses across…

Continue ReadingClover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults

Single Ingredient Supplements: PureHealth Research Highlights a Targeted Approach to Everyday Wellness

  • Post author:
  • Post category:Sales & Growth

MANASSAS, Va., Sept. 5, 2026 /PRNewswire/ -- PureHealth Research is spotlighting a noticeable shift in how people approach their daily wellness routines, with more consumers than ever gravitating toward simpler, more transparent supplement formulations. Rather than reaching for a…

Continue ReadingSingle Ingredient Supplements: PureHealth Research Highlights a Targeted Approach to Everyday Wellness

Pediatric Dental Expert Dr. Marjan Rashedi Explains Laughing Gas and Nitrous Oxide Safety for Children in HelloNation

  • Post author:
  • Post category:Sales & Growth

The article explains how laughing gas supports anxiety control, safe dental procedure care, and preventive care for children's teeth.SAN MARCOS, Calif., Sept. 5, 2026 /PRNewswire/ --Is laughing gas safe for children at a San Marcos pediatric dentist? HelloNation…

Continue ReadingPediatric Dental Expert Dr. Marjan Rashedi Explains Laughing Gas and Nitrous Oxide Safety for Children in HelloNation